Last updated on August 7th, 2026 at 04:08 pm
Last updated on August 7th, 2026 at 04:08 pm
The HILL Model: Treating Concussion Neuroinflammation with Low-Dose Lithium
Understanding the HILL Model: Head Impact, Concussions, Inflammation, and Nutritional Low-Dose Lithium for Prevention and Recovery
Beyond Symptoms: The HILL Model for Concussion Recovery
Introduction: Rethinking Brain Injury, Prevention, and Recovery
Rethinking Concussion Treatment with Low-Dose Lithium
For millions of athletes and military personnel, a concussion is often treated as a temporary setback, managed primarily through rest and symptom monitoring. However, this traditional protocol overlooks the critical biological engine driving the injury: neuroinflammation. Emerging research is shifting the conversation from physical impact alone to the cumulative inflammatory cascade that can lead to long-term cognitive decline and conditions like CTE.
Enter the HILL model—a revolutionary framework that integrates Head impact mechanics, the Inflammatory response, and the protective potential of Low-dose lithium (LL) to mitigate secondary brain injury. By reframing concussion as a modifiable biological process rather than a static mechanical event, the HILL model offers a proactive, precision-based pathway for better recovery and long-term brain health. To dive into the full science and the complete data behind this framework, you can access the full publication in the Trends Open journal here.H2: What is the HILL Model?.
The HILL model: Head impact, Inflammation, and Low-dose lithium
The HILL model—which stands for Head impact, Inflammation, and Low-dose lithium—is a scientific framework designed to reframe how we understand concussion and brain injury. For decades, the medical community has treated concussions as binary “events”—you either have one, or you don’t, and the primary recovery tool has been rest.
The HILL model shifts this perspective. It proposes that concussions and subconcussive head impacts are not just mechanical events; they are biologically modifiable processes. When a head impact occurs, it sets off a “domino effect” inside the brain:
- Head Impact (H): Mechanical forces (acceleration and deceleration) cause shear stress on brain tissue, disrupting cell membranes and axons.
- Inflammation (I): This physical trauma acts as a trigger, causing the brain's immune cells (microglia and astrocytes) to become hyperactive. This creates an "inflammatory cascade"—a surge of cytokines that leads to secondary injury and energy crises in the brain.
- Low-Dose Lithium (L): The "modulator." While lithium is historically associated with high-dose psychiatric use, low-dose (nutritional level) lithium acts differently. It can help "dampen" the inflammatory surge, stabilize mitochondria, and protect neurons.
The Science of Concussion: Why Rest Alone Isn't Enough
While the skull provides rigid external protection, neural tissue has not evolved to withstand the rapid acceleration and deceleration of modern contact sports. Even impacts below the threshold of a diagnosed concussion can disrupt neuronal membranes and stretch axons.
Why Neuroinflammation is the Real Driver of Injury
When these impacts occur, the blood–brain barrier may become compromised, allowing peripheral cytokines to enter the brain. This triggers a feed-forward loop of inflammation. If these impacts occur in rapid succession, the brain has insufficient time to resolve its response, leading to a cumulative inflammatory burden that characterizes long-term issues like CTE.
Why Low-Dose Lithium Could Be a Game-Changer.
When we talk about lithium, the conversation is often clouded by its history as a high-dose psychiatric medication. However, the HILL model proposes using low-dose or microdose lithium—roughly 1% to 10% of standard psychiatric doses—not as a mood-altering drug, but as a “nutrient-modulator”. At these low levels, lithium offers several promising mechanisms:
- Inhibiting the "Inflammatory Hub" (GSK-3β): Lithium helps inhibit glycogen synthase kinase-3β (GSK-3β), a protein that acts as a control center for neuroinflammation.
- Blocking the Inflammasome (NLRP3): It can block the assembly of the NLRP3 inflammasome, effectively "turning down the volume" on the brain's overactive immune response.
- Mitochondrial Protection: Lithium helps stabilize mitochondrial membranes, supporting the brain's recovery from the energy crisis that follows an impact.
Implementation and Future Directions
The HILL model proposes a three-phase approach to concussion management:
- Prophylaxis (Pre-Impact): Establishing a baseline of nutritional lithium to provide "biochemical preconditioning," potentially raising the threshold at which forces trigger inflammation.
- Acute Response: Administering low-dose lithium within the narrow therapeutic window following an impact to blunt the acute cytokine surge.
- Recovery Optimization: Continuing low-dose lithium post-injury to support neuroimmune regulation and prevent microglia from remaining "primed" for future injury.
Future Directions for Brain Health
The HILL model argues that the long-term consequences of head impacts do not have to be an inevitable fate. By integrating wearable sensors to track impact forces, measuring blood-based inflammatory biomarkers, and utilizing low-dose lithium, sports medicine and public health systems can shift from simply managing concussion symptoms to actively building brain resilience.
About the Lead Researcher: Dr. Sudhir Gadh
Dr. Sudhir Gadh is a New York City-based psychiatrist and an affiliate researcher at the Karolinska Institute in Sweden and the Galicia Sur Health Research Institute in Spain. With a background as a commander in the U.S. Navy Medical Corps Reserve, his clinical and research work focuses on neuroinflammation, biomarker-driven psychiatry, and the role of low-dose lithium in mental health, neurodegeneration, and performance medicine. He is the principal investigator of the Karolinska Lithium-Inflammation Psychiatry (LIP) Study and a pioneer in integrating clinical practice with systems-level approaches to improve long-term brain resilience.
Conclusion
The future of concussion management is shifting from symptom-based reaction to mechanism-based intervention. The HILL model represents a bold, testable roadmap for protecting the brains of athletes, military personnel, and aging adults alike. If we are to move past the era of invisible injuries, we must embrace a biology-driven approach.
Read the Full Story
To explore the foundational data and the full scientific argument for this paradigm shift, read the complete publication in the Read the complete peer-reviewed Trends Open journal article here: HILL model: Head impact, inflammation, low-dose lithium. Are you ready to prioritize long-term brain resilience? Bookmark this research, share it with your coaching staff or medical providers, and join the conversation on demanding better, science-backed concussion protocols.